Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;1863(5):1078-1089.
doi: 10.1016/j.bbadis.2016.08.018. Epub 2016 Aug 25.

Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal

Ramesh Kandimalla  1 , Vani Thirumala  2 , P Hemachandra Reddy  3
Affiliations
Review

Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal

Ramesh Kandimalla et al. Biochim Biophys Acta Mol Basis Dis. 2017 May.

Abstract

Recently researchers proposed the term 'Type-3-Diabetes' for Alzheimer's disease (ad) because of the shared molecular and cellular features among Type-1-Diabetes, Type-2-Diabetes and insulin resistance associated with memory deficits and cognitive decline in elderly individuals. Recent clinical and basic studies on patients with diabetes and AD revealed previously unreported cellular and pathological among diabetes, insulin resistance and AD. These studies are also strengthened by various basic biological studies that decipher the effects of insulin in the pathology of AD through cellular and molecular mechanisms. For instance, insulin is involved in the activation of glycogen synthase kinase 3β, which in turn causes phosphorylation of tau, which involved in the formation of neurofibrillary tangles. Interestingly, insulin also plays a crucial role in the formation amyloid plaques. In this review, we discussed significant shared mechanisms between AD and diabetes and we also provided therapeutic avenues for diabetes and AD. This article is part of a Special Issue entitled: Oxidative Stress and Mitochondrial Quality in Diabetes/Obesity and Critical Illness Spectrum of Diseases - edited by P. Hemachandra Reddy.

Keywords: Alzheimer's disease; BMI; GSK3β; MCI amyloid beta; Obesity; Tau; Type-3-Diabetes; diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of T2DM/insulin resistance in Alzheimer’s disease through a) mitochondrial dysfunction, which in turn causes synaptic damage, and neuronal death, b) glycosylated hemoglobin in impaired cognitive function by failure in the transport of glucose for neurons, c) oxidative stress-induced amyloid beta and phosphorylated tau formations through advanced glycation end products , d) inflammation by mitochondrial dysfunction and toxicities of amyloid beta and glycation end products, e) activation of voltage-dependent anion channel by amyloid beta-induction in neuronal loss.
Figure 2
Figure 2
Insulin resistance in T2DM causes mitochondrial dysfunction, which in turn triggers inflammation response through either APP/hIAPP catabolism. Amyloid beta oligomers activate microglia in the production of cytokines. An orchestrated action triggered by stress kinases promotes both the inhibition of brain insulin signaling and elevated eIF2a–P. While both events act to promote insulin resistance and metabolic deregulation in diabetes, they are likely to contribute to synapse loss and impaired long-term potentiation.
Figure 3
Figure 3
Insulin resistance decreases glucose metabolism and plays a pivotal role in mitochondrial damage, DNA damage and ROS formation. This triplet action is involved in the formation of plaques.
Figure 4
Figure 4
Brief Illustration of insulin signaling pathway in a) healthy brain and b) AD brain. (Figure concept adapted from “Trends Neurosci. 2016 Jun 17. pii: S0166-2236(16)30037-6. “)
Figure 5
Figure 5
Role of amyloid beta oligomers on toxic effects of synapses, including synaptic degeneration, abnormal neurotransmitter release and cytoskeletal damage. Synaptotoxic effects cause defective axonal transport, mitochondrial fragmentation, degradation of kinases activity, oxidative stress, impaired LTP, increase in intracellular calcium levels.
Figure 6
Figure 6
Illustration of hypothalamus in the brain plays a crucial role in energy homeostasis by regulating two opposing neuronal axes, namely orexigenic axis and anorexigenic axis
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alzheimer’s Association Report. 2015.
    1. Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta. 2016 http://dx.doi.org/10.1016/j.bbadis.2016.04.017. - DOI - PMC - PubMed
    1. Kandimalla R, Reddy PH. Multiple faces of dynamin-related protein 1 and its role in Alzheimer’s disease pathogenesis. Biochim Biophys Acta. 2016;1862:814–828. - PMC - PubMed
    1. Kandimalla RJ, Prabhakar S, Binukumar BK, Wani WY, Gupta N, Sharma DR, Sunkaria A, Grover VK, Bhardwaj N, Jain K, Gill KD. Apo-Eepsilon4 allele in conjunction with Abeta42 and tau in CSF: biomarker for Alzheimer’s disease. Curr Alzheimer Res. 2011;8:187–196. - PubMed
    1. Kandimalla RJ, Anand R, Veeramanikandan R, Wani WY, Prabhakar S, Grover VK, Bharadwaj N, Jain K, Gill KD. CSF ubiquitin as a specific biomarker in Alzheimer’s disease. Curr Alzheimer Res. 2014;11:340–348. - PubMed

Publication types